Jim Gollan has over 25 years experience operating at Board level in financial services both as executive and non executive director. Currently, Jim is a non executive Director and Chair of Audit Committee of Citibank Europe and Non Executive Director and Chair of Audit Committee for Euronext NV and he is the Chair of the Board for Euronext London. Previously, his roles included Chair of the Board Bank of America Merrill Lynch International Ltd.
Jonathan Kropman is a Partner at lawyers,Trowers and Hamlins LLP, where he leads the international private client group; previously he held the same role as a Partner at Berwin Leighton Paisner LLP. Jonathan’s legal practice includes advising on governance, holding structures, investment and shareholders’ agreements for the wealth management industry and the firm’s private client base. He is also a Trustee of Weizmann Institute Foundation, a registered charity.
Jerry Storrs is a Chartered Accountant and Corporate Treasurer and currently works as an independent advisor and board director. In a wide-ranging career, most recently specialising in corporate debt restructuring and the sale of "non-core" assets, he has negotiated numerous high profile and high value transactions. During a secondment to the Civil Service he advised ministers on corporate finance transactions and policy. Earlier in his career he held senior roles in banking as a divisional COO / CFO.
Vijay is Assistant Director of Policy & Strategic Partnerships at the National Emergencies Trust, a charity set up to raise funds and support people affected by disasters in the UK. He is also a Trustee of Thames Valley Air Ambulance, was previously Head of Fundraising Strategy at the British Red Cross, and has worked in the charity sector for over 12 years, with experience also in public affairs, research and risk management.
Aoife Regan has over 15 years' experience of working in one of the largest fundraising charities in the world – Cancer Research UK. She is currently Head of Experimental Cancer Medicine there and her previous roles include Head of Research Evaluation and Senior Strategy Manager. She has a PhD in Developmental Neuroscience.
Kevin Talbot MBBS, DPhil, FRCP is Professor of Motor Neuron Biology, and of the Nuffield Department of Clinical Neurosciences, at the University of Oxford. He is a Fellow of Pembroke College, Oxford. His research focusses on using laboratory models to find new treatments for motor neuron disease (amyotrophic lateral sclerosis). He is a clinically active specialist in neurological diseases and co-leads the Oxford Motor Neuron Disease Centre.
Professor Joanna Wardlaw, CBE, MD, FRSE, FMedSci, is Professor of Applied Neuroimaging at the University of Edinburgh, Foundation Chair in the UK Dementia Research Institute, and Consultant Neuroradiologist for NHS Lothian. Her work focuses on understanding the brain and its blood supply, and on treatments to improve blood flow to the brain, including thrombolytic drugs that are now in routine use to treat stroke, and more recently on treatments for small vessel disease and dementia.
Paul Wright is currently a non-executive director of fibodo and of qodeo, both early stage tech-enabled businesses. His executive career included 40 years as a Finance Director/CFO in various financial services businesses, including Towry, Man Investments, Coutts and Standard Chartered, as well as experience in venture capital and private equity.
